Programme Budgeting – Testing The Approach in Scotland
This paper describes the pilot application of Programme Budgeting and Marginal Analysis (PBMA) in Scotland. Within the Health Care Quality Strategy for NHSScotland one of the three quality ambitions is concerned with providing a more efficient and effective health service. This paper supports this ambition by discussing how outcome measures could be used, along with cost data disaggregated in this way, to inform discussions around the value for money associated with different programmes.
4. Preliminary findings - top down approach
Activity
27. NHSScotland activity was allocated to the 21 programmes, with the exception of A&E, community, and prevention activity and expenditure, which it was not possible to disaggregate at this time. Total activity by programme is disaggregated and shown in Table A1 in Appendix A.
Expenditure
28. Overall, all NHS Scotland expenditure was allocated to the 21 programmes (Table A2 in Appendix A). The biggest category was 'other', which incorporates much of the community activity in Scotland as well as other activity that cannot be allocated by diagnostic category. The high level (estimated) results are shown in Table 4.1 with proportions from the English PB exercise included for comparison.
Table 4.1: Programme budgeting categories & associated estimated spend
Programme Budgeting Category | All Services | Percentage | % from English PB exercise |
---|---|---|---|
All Other | £2,363,206,181 | 29.3% | 31.4% |
Problems of circulation | £756,720,451 | 9.4% | 7.8% |
Mental Health Disorders | £728,254,492 | 9.0% | 11.0% |
Problems of the respiratory system | £508,300,584 | 6.3% | 4.0% |
Problems of the gastro intestinal system | £481,524,197 | 6.0% | 4.4% |
Cancers and Tumours | £475,299,004 | 5.9% | 5.3% |
Neurological | £437,592,278 | 5.4% | 3.7% |
Dental problems | £374,083,410 | 4.6% | 3.2% |
Problems due to Trauma and Injuries | £357,432,705 | 4.4% | 3.3% |
Problems of Genito Urinary system | £314,612,189 | 3.9% | 3.9% |
Problems of the Musculo skeletal system | £290,808,712 | 3.6% | 4.4% |
Problems of the Skin | £203,331,806 | 2.5% | 1.8% |
Endocrine, Nutritional and Metabolic problems | £195,824,862 | 2.4% | 2.6% |
Problems of Vision | £185,093,353 | 2.3% | 1.7% |
Infectious diseases | £85,184,967 | 1.1% | 1.4% |
Adverse effects and poisoning | £89,540,357 | 1.1% | 0.9% |
Maternity and Reproductive Health* | £77,496,004 | 1.0% | 3.2% |
Disorders of Blood | £65,608,322 | 0.8% | 1.3% |
Problems of Learning Disability | £49,220,106 | 0.6% | 3.0% |
Problems of Hearing | £24,565,963 | 0.3% | 0.5% |
Conditions of neonates* | £1,989,574 | 0.0% | 1.0% |
Total expenditure | £8,065,689,520 | 100% | 100% |
* the majority of these data are currently included in the other category
Data source: ISD data request
29. A few of the estimates presented are worthy of comment. At the time of analysis it was not possible to map maternity spend and as a result the majority of the data is in the "other" category. This problem is being resolved. We are aware of data quality and completeness issues with LD data across both hospital and community care, so this category should be treated with caution and the low percentage will be one of the resulting effects. Conversely dental spend may seem high, in relative terms, because it was possible to map comprehensively from existing datasets to the programme budgeting category.
30 Table A2 in the Appendix further disaggregates the spend shown in Table 4.1, allowing comparison across programmes in terms, for example, of acute services, out patients, GP attendances or primary care prescribing.
32 Figure 1 is a graphical representation of some of the data in Table 4.1. It shows the relative proportion of total spend across the programme budget categories in England and Scotland. Although not presented here, a similar analysis could be done for elements of the total spend such as GMS or prescribing or acute care. Also, within a programme budget, the data shows the distribution of spend across different care settings. The availability of time series would enable analysis of any shifts in these.
Detailed programme budgets
33. Four programme budgets were identified for further examination - mental health, cancer services, diabetes and stroke. Information and expenditure relating to A&E and community services were unable to be allocated to individual programmes. For the diabetes and stroke sub programmes, it was not possible to allocate outpatient activity and costs.
4.1 Mental health
34. Mental health disorders form a programme budget category in their own right. Total expenditure was estimated to be £728 million, which represents 9% of total NHSScotland expenditure. The programme budget is subdivided into 5 separate sub programmes - substance misuse, organic mental disorders, psychotic disorders, child & adolescent (C&A) mental health disorders and other mental health disorders. Table 4.2 shows the activity associated with these sub programmes and with the different service provision.
Table 4.2: Mental health estimated activity
Sub programme |
Acute services episodes |
Geriatric long stay episodes |
Mental health & learning disabilities episodes |
OP attendances |
Pharmaceutical items dispensed |
GMS visits |
---|---|---|---|---|---|---|
Substance misuse | 5,323 | 17 | 3,566 | - | 816,808 | 184,365 |
Organic MH disorders | 3,208 | 599 | 3,657 | - | 95,819 | 21,959 |
Psychotic disorders | 297 | 4 | 8,829 | - | 693,301 | 25,079 |
Child and Adolescent MH disorders[16] | 24 | - | 12 | 27,259 | 71,794 | 788 |
Other MH disorders | 1,863 | 21 | 8,055 | 252,191 | 5,949,285 | 767,671 |
All | 10,714 | 641 | 24,119 | 279,450 | 7,627,007 | 999,863 |
Data source: ISD data request
Note: these figures have been apportioned across all activity to ensure they cover the activity figures reported in the Costs Book
The associated expenditure is shown in table 4.3
Table 4.3: Mental health estimated expenditure
Total (£) |
Acute services episodes (£) |
Geriatric long stay episodes (£) |
Mental health & learning disabilities (£) |
OP services (£) |
Pharma- ceutical items dispensed (£) |
GMS visits (£) |
|
---|---|---|---|---|---|---|---|
Substance misuse | 63,882,023 | 7,014,704 | 188,296 | 28,629,093 | 0 | 22,083,882 | 5,966,048 |
Organic MH disorders | 169,203,520 | 19,332,568 | 16,087,125 | 12,1717,842 | 0 | 11,355,377 | 710,608 |
Psychotic disorders | 239,842,417 | 776,063 | 57,007 | 203,349,257 | 0 | 34,848,537 | 811,553 |
Child and Adolescent MH disorders | 11,058,935 | 68,354 | 0 | 746,637 | 5,984,579 | 4,233,858 | 25,507 |
Other MH disorders | 244,267,596 | 4,389,840 | 361,292 | 118,967,816 | 38,674,192 | 57,032,602 | 24,841,855 |
All | 728,254,492 | 31,581,529 | 16,693,721 | 473,410,644 | 44,658,771 | 129,554,256 | 32,355,571 |
Data source: ISD data request
Outcomes associated with mental health services
Process outcomes
- Early diagnosis and treatment of dementia
- Alcohol brief interventions delivered
- Readmissions within 28 / 133 days
Intermediate outcomes
- Reduced suicide rates / 1000 population
4.2 Cancer services
35. Cancer is a programme budgeting category in its own right and is split into 8 sub programmes, reflecting the major tumour sites. Cancer services estimated expenditure was £475 million, representing 5.9% of total NHSScotland budget. This excludes cancer screening programmes, which are included in the 'other' category. Additionally we know that activity and cost associated with radiotherapy may not well captured by the data.
Table 4.4: Cancer services estimated activity
Sub programme | Acute services episodes |
Geriatric long stay episodes |
OP services |
Pharmaceutical items dispensed |
GMS visits |
---|---|---|---|---|---|
Cancer, Head and Neck | 5,354 | 9 | 2,739 | ||
Cancer, Upper GI | 14,504 | 56 | - | 9,878 | |
Cancer, Lower GI | 23,030 | 76 | 74 | 8,030 | |
Cancer, Lung | 18,166 | 95 | - | 11,844 | |
Cancer, Skin | 5,885 | 2 | - | 5,334 | |
Cancer, Breast | 24,223 | 35 | 140,441 | 10,422 | |
Cancer, Gynaecological | 10,590 | 15 | 4,091 | 2,636 | |
Cancer, Urological | 13,583 | 67 | 32,802 | 18,606 | |
Cancer, Haematological | 27,179 | 41 | - | 5,753 | |
Cancers and Tumours | 45,627 | 121 | 976,206 | 120,120 | |
All | 188,141 | 517 | 144,624 | 1,153,614 | 195,363 |
Data source: ISD data request
Table 4.5: Cancer services estimated expenditure
Total (£) | Acute services episodes (£) |
Geriatric long stay episodes (£) |
OP services (£) |
Pharmacy items dispensed (£) |
GMS visits (£) |
|
---|---|---|---|---|---|---|
Cancer, Lower GI | 60,978,784 | 59,683,596 | 1,010,581 | 24,753 | 259,853 | |
Cancer, Lung | 47,939,226 | 46,216,400 | 1,339,545 | 0 | 383,282 | |
Cancer, Skin | 9,553,213 | 9,337,406 | 43,187 | 0 | 172,620 | |
Cancer, Breast | 47,632,653 | 34,210,952 | 1,228,245 | 11,856,203 | 337,253 | |
Cancer, Gynaecological | 18,996,935 | 18,704,807 | 83,166 | 123,667 | 85,294 | |
Cancer, Urological | 39,065,959 | 30,356,771 | 1,205,788 | 6,901,309 | 602,092 | |
Cancer, Haematological | 51,530,511 | 50,528,473 | 815,869 | 0 | 186,170 | |
Cancers and Tumours | 146,101,588 | 88,274,471 | 2,050,777 | 26,832,657 | 3,887,085 | |
All | 475,299,004 | 389,749,741 | 8,432,124 | 25,056,598 | 45,738,589 | 6,321,952 |
Data source: ISD data request
Outcomes associated with cancer services
36. There are a range of outcome measures, including morbidity and mortality data, and comparative data with EUROCARE. This is collected and published by the Scottish Cancer Registration Scheme, managed by ISD. Information about the process of cancer care is collected by the cancer networks on an individual cancer basis.
4.3 Diabetes
37. Diabetes is not a programme budget category in its own right, but comes under the programme 'endocrine, nutritional and metabolic problems' which together account for an estimated £196 million expenditure (2.4% total budget). Within this, diabetes accounts for total expenditure of £93 million, or 1.2% of the NHSScotland budget.
Table 4.6: Diabetes estimated activity
Acute services episodes |
Geriatric long stay episodes |
Pharmaceutical items dispensed |
GMS visits |
---|---|---|---|
5,996 | 71 | 2,620,120 | 451,692 |
Data source: ISD data request
Table 4.7: Diabetes estimated expenditure
Total (£) | Acute services episodes (£) |
Geriatric long stay episodes (£) |
Pharmaceutical items dispensed (£) |
GMS visits (£) |
---|---|---|---|---|
93,000,152 | 11,964,874 | 1,906,408 | 64,512,096 | 14,616,774 |
Data source: ISD data request
Outcomes associated with diabetes services
Process outcomes
- Attendances at retinal screening
- Attendances at structured education
- Use of intensive insulin therapy
- Attendances at foot screening
Intermediate outcomes
- Reduced incidence of sequelae, including nerve/ eye/ kidney/ cardiovascular disease
Comment
38. This is likely to be a significant underestimate of the cost of diabetes to NHSScotland. For example, the Department of Health's advisory body, NHS Diabetes estimates that care of people with diabetes consumes around 5-8% of the UK NHS budget, while Diabetes UK estimate the cost is around 10%.
39. There are a number of reasons why this may be the case, including:
- the use of first diagnostic place for hospital data as the determinant of programme budget, as many diabetes related admissions would be categorised according to the complication or co-morbidity rather than diabetes.
- the inability to allocate outpatient and community activity (the majority of diabetes care occurs in primary care) and expenditure to this programme budget.
4.4 Stroke
40. Like diabetes, stroke forms part of a larger programme budget grouping, in this case, 'problems of circulation', which together accounts for an estimated £757 million expenditure (9.4% of total) and forms the largest clinical programme budget group. Within this programme, estimated stroke expenditure is £146 million, or 1.8% of total NHSScotland expenditure.
Table 4.8: Stroke estimated activity
Acute services episodes |
Geriatric long stay episodes |
Mental health & learning disabilities |
Pharmaceutical items dispensed |
GMS visits |
---|---|---|---|---|
20,671 | 792 | 1 | 1,095,584 | 259,420 |
Data source: ISD data request
Table 4.9: Stroke estimated expenditure
Total (£) | Acute services episodes (£) |
Geriatric long stay episodes (£) |
Mental health & learning disabilities (£) |
Pharmaceutical items dispensed (£) |
GMS visits (£) |
---|---|---|---|---|---|
146,453,319 | 104,629,685 | 24,438,551 | 8,344 | 8,891,918 | 8,394,821 |
Data source: ISD data request
Outcomes associated with stroke services
Process outcomes
- Use of primary and secondary prevention
- Administration of thrombolysis
- Admission to stroke units
- Access to imaging
Intermediate outcomes
- TIAs and strokes prevented
- Improved 30 day survival
- Reduced long term disability
Contact
Email: Marjorie Marshall
There is a problem
Thanks for your feedback